Hepatocellular carcinoma: contrast enhancement with Levovist.
OBJECTIVE
To present the sonographic appearance of hepatocellular carcinoma imaged with the intravenous contrast agent Levovist.


METHODS
We reviewed our experience using Levovist (Schering AG, Berlin, Germany) for the sonographic diagnosis of hepatocellular carcinoma.


RESULTS
Contrast-enhanced sonography with Levovist facilitated detailed evaluation of tumor vascularity in hepatocellular carcinoma.


CONCLUSIONS
Contrast-enhanced sonography with Levovist enhances the role of sonography in the diagnosis of hepatocellular carcinoma. It provides detailed information about tumor vascularity and the contrast enhancement pattern.
Choi
Byung Ihn
BI
Department of Radiology and Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Korea.
Kim
Ah Young
AY
Lee
Jae Young
JY
Kim
Kyoung Won
KW
Lee
Kyoung Ho
KH
Kim
Tae Kyoung
TK
Han
Joon Koo
JK
D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging*; D003287:Contrast Media; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging* / Q000473:pathology; D008113:Liver Neoplasms / Q000000981:diagnostic imaging*; D011134:Polysaccharides; D016896:Treatment Outcome; D018608:Ultrasonography, Doppler; D018615:Ultrasonography, Doppler, Color
D003287:Contrast Media; D011134:Polysaccharides; C059891:SHU 508